Evaluation of a Digital Support and Communication Platform for COPD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Copd
- Sponsor
- Lund University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Number of hospital days during intervention and up 12 months after inclusion
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
To evaluate whether a digital support and communication platform for COPD patients after 6 months provides:
- Decreased breathlessness on the basis of modified medical research council dyspnea scale [mMRC]
- Improved health status and symptom relief based on COPD assessment scale [CAT]
- Improved quality of life based on EQ-5D
- Reduction in the number of incidents, hospital nights, the number of hospitalizations, outpatient contacts or the number of deaths related to COPD
- A change in the classification of COPD severity based on GOLD A-D
Investigators
Sofia Gerward
Principal Investigator, MD, PhD
Lund University
Eligibility Criteria
Inclusion Criteria
- •The patient is included in the study in connection with visits to COPD.
- •Diagnosed COPD J44 (newly discovered or existing)
- •Have completed the consent form
- •Is judged to be able to handle the intervention himself or with the help of staff or relatives
Exclusion Criteria
- •Patient who declines to participate in the trial.
- •Impaired cognitive ability that is judged to affect the ability to conduct the study in the intended manner.
- •Life expectancy \<8 months
- •In other ways, treating physicians are deemed to be inappropriate to participate in the study, e.g. due to participation in another study.
Outcomes
Primary Outcomes
Number of hospital days during intervention and up 12 months after inclusion
Time Frame: 12 months
Change in health status and symptom relief based on COPD assessment scale [CAT]
Time Frame: 6 months
Health status and symptom is evaluated with COPD assessment scale (CAT) where the scale is from 0-40 and where high score represent worse health status and symptoms
Change in quality of life
Time Frame: 6 months
Improved quality of life as measured on visual analogue scale 0-100 where high figure represent best quality of life
A change in the classification of COPD severity based on GOLD A-D
Time Frame: 6 months
A change in the classification of COPD severity based on GOLD 1-4 (A-D) where high figure represent worse severity
Change in patient reported symptoms
Time Frame: 6 months
Improved patient-reported symptoms as measured by questionnaire EuroQol three-dimensional questionnaire (EQ-5D-3L ) where high score represent worse symptoms. The minimum score is 7 points and the maximum score is 23 points.
Severity of dyspnea on the basis of modified medical research council dyspnea scale [mMRC]
Time Frame: 6 months
Dyspnea is measured with mMRC from 0-4 where high figure represent dyspnea in minimal exertion
Number of participants with new hospitalization up 12 months after inclusion
Time Frame: 12 months
Number of health care visits during intervention and up to 12 months after inclusion
Time Frame: 12 months
Number of participants with COPD related events and deaths during intervention and up to 12 months after inclusion
Time Frame: 12 months